Free 24-hour delivery over £75 · Same-day dispatchOrder before 2pm - same-day dispatch · Free 24-hour delivery over £75
GH Axis
CJC-1295 (DAC)
- Purity
- >= 99% (HPLC)
- Form
- Lyophilised powder
- Origin
- United States
Manufactured for laboratory research. Not for human or veterinary use. Read full disclaimer →
CJC-1295 (with DAC) is a synthetic growth-hormone-releasing hormone (GHRH) analogue carrying a drug-affinity-complex modification for an extended half-life, studied in research into GHRH-receptor signalling and the GH axis in experimental models.
- Purity >= 99% (HPLC)
- Supplied as a lyophilised powder
- Independent batch identity and purity testing
- For laboratory research use only; not for human or veterinary use
What is CJC-1295 with DAC?
CJC-1295 with DAC is a synthetic growth-hormone-releasing-hormone (GHRH) analog bearing a Drug Affinity Complex (DAC) moiety that binds serum albumin to extend its plasma half-life. It carries the molecular formula C165H269N47O46, a molecular weight of 3647.2 g/mol and CAS number 446262-90-4. It is supplied as a lyophilised solid for laboratory research.
The DAC version is the long-acting form. The DAC tail is the only difference between this material and the non-DAC peptide sold as a separate research compound: see CJC-1295 (no DAC) for the short-acting analog. Both sit within the same GHRH-receptor class.
Is CJC-1295 with DAC legal in the UK?
CJC-1295 with DAC is not a controlled drug under the Misuse of Drugs Act 1971, and it holds no UK marketing authorisation as a medicine. Kovalabs supplies it strictly as a research chemical for laboratory use only. It cannot be sold or labelled for human or veterinary consumption, and responsibility for lawful, compliant handling rests with the purchaser. See our research disclaimer for the full terms.
How is identity and quality assured?
Each batch is released only after independent analytical testing. Purity is assessed by HPLC at 99% or greater, and identity is confirmed against the expected mass for C165H269N47O46. The compound is cross-referenced to CAS 446262-90-4 and PubChem CID 91971820 so the molecule in the vial matches the published record. Per-batch certificates of analysis are available on the CoA page.
What does the research on CJC-1295 with DAC investigate?
The published literature examines CJC-1295 as a long-acting GHRH-receptor agonist in pre-clinical and pharmacokinetic models, with the DAC moiety studied for its effect on circulating half-life. Anti-doping laboratories also study its detection. None of this establishes a benefit, effect or outcome in humans, and it is not a licensed medicine. The mechanistic and evidence detail is handled in the CJC-1295 DAC research monograph.
Synthesis and supply
CJC-1295 with DAC is manufactured to research grade and shipped as a lyophilised white to off-white powder. For bench work it is reconstituted in bacteriostatic water; store the lyophilised solid at -20C, dry and protected from light, and hold reconstituted material at 2-8C. Browse the full GH-axis category or related research compounds including Ipamorelin and Sermorelin. Supplied for laboratory research use only; not for human or veterinary use.
- 2D structure
- Product name
- CJC-1295 with DAC
- Synonyms
- CJC-1295 DAC, DAC:GRF
- Molecular formula
- C165H269N47O46
- Molecular weight
- 3647.2 g/mol
- CAS number
- 446262-90-4
- PubChem CID
- 91971820
- Purity
- >= 99% (HPLC)
- Form
- Lyophilised powder
- Appearance
- White to off-white solid
- Solubility
- Bacteriostatic water
- Storage
- Lyophilised: store at -20C, dry and light-protected. Reconstituted: 2-8C.
- What is CJC-1295 with DAC?
- CJC-1295 with DAC is a synthetic GHRH (growth-hormone-releasing-hormone) analog carrying a Drug Affinity Complex moiety that binds serum albumin to extend its plasma half-life. Its molecular formula is C165H269N47O46, molecular weight 3647.2 g/mol, CAS number 446262-90-4. Kovalabs supplies it as a lyophilised solid for laboratory research use only.
- What is the difference between CJC-1295 with DAC and CJC-1295 no DAC?
- The DAC (Drug Affinity Complex) moiety is the only structural difference. The DAC form is the long-acting analog, while the no-DAC form is short-acting; both are GHRH-receptor research peptides. They are sold as two distinct research compounds. This listing is the DAC version; the short-acting material is on the separate CJC-1295 (no DAC) product page.
- Is CJC-1295 with DAC legal in the UK?
- CJC-1295 with DAC is not a controlled drug under the Misuse of Drugs Act 1971, and it holds no UK marketing authorisation as a medicine. Kovalabs supplies it as a research chemical for laboratory use only. It cannot be sold or labelled for human or veterinary consumption, and the purchaser is responsible for lawful, compliant handling.
- Is CJC-1295 with DAC intended for human use?
- No. CJC-1295 with DAC is supplied strictly as a research chemical for in-vitro and laboratory investigation. It is not intended, labelled or sold for human or veterinary use, is not a licensed medicine, and must not be administered to people or animals. It is a reference material for non-clinical research only.
- Has CJC-1295 with DAC been shown to be safe or effective in humans?
- No. The literature investigates CJC-1295 as a long-acting GHRH-receptor agonist in pre-clinical and pharmacokinetic models. None of that work establishes a benefit, effect, safety profile or outcome in humans, and it is not a licensed medicine. Any human reading of the research is not supported. It is supplied for laboratory research use only.
- What does the research on CJC-1295 with DAC investigate?
- Published studies examine CJC-1295 as a GHRH-receptor agonist in pre-clinical and pharmacokinetic models, with the DAC moiety studied for its effect on circulating half-life, plus anti-doping detection methods. This describes a research area, not a human benefit; none of it establishes an effect or outcome in people. Mechanistic depth is covered in the CJC-1295 DAC research monograph.
- Are all CJC-1295 with DAC products the same?
- No. Purity and identity vary by supplier and batch. Kovalabs releases each batch only after independent testing: HPLC purity of 99% or greater and identity confirmed against the expected mass for C165H269N47O46. Per-batch certificates of analysis are published on the CoA page so the documented identity matches the material supplied.
- What are the molecular identifiers for CJC-1295 with DAC?
- CJC-1295 with DAC has the molecular formula C165H269N47O46 and a molecular weight of 3647.2 g/mol. It is identified by CAS number 446262-90-4 and PubChem CID 91971820. It is also known as CJC-1295 DAC and DAC:GRF. These identifiers let a laboratory confirm the compound against the public chemical record.
- Is CJC-1295 with DAC a peptide?
- Yes. CJC-1295 with DAC is a synthetic peptide, specifically a modified analog of growth-hormone-releasing-hormone (GHRH) joined to a Drug Affinity Complex moiety. It is not a steroid and not a small-molecule drug. It is supplied as a lyophilised peptide solid for laboratory research use only.
- How is CJC-1295 with DAC supplied and reconstituted?
- It is supplied as a lyophilised white to off-white powder. For bench work it is reconstituted in bacteriostatic water, which Kovalabs stocks as a separate research product. The stated milligram strength is a product specification, not a usage instruction. The material is for laboratory research only and is not intended for administration to humans or animals.
- How should CJC-1295 with DAC be stored?
- Store the lyophilised powder at -20C, kept dry and protected from light, where it is stable long term. Once reconstituted in bacteriostatic water, hold the solution at 2-8C and protect it from light. Avoid repeated freeze-thaw cycles. These conditions preserve peptide integrity for laboratory research handling.
- Does CJC-1295 with DAC come with a certificate of analysis?
- Yes. Every batch is released with a certificate of analysis documenting HPLC purity of 99% or greater and identity confirmed against the expected mass. Certificates are available on the Kovalabs CoA page, cross-referenced to CAS 446262-90-4 and PubChem CID 91971820 so the documented identity matches the supplied material.
- Where can I buy CJC-1295 with DAC in the UK?
- CJC-1295 with DAC is available from Kovalabs for UK despatch, supplied as a lyophilised research-grade peptide with a per-batch certificate of analysis and 99% or greater HPLC purity. It is sold strictly for laboratory research use only and cannot be supplied for human or veterinary consumption.
- What is the WADA status of CJC-1295 with DAC?
- GHRH analogs such as CJC-1295 fall under the World Anti-Doping Agency Prohibited List as growth-hormone secretagogues (class S2), prohibited at all times in sport. This is stated as regulatory context only. It does not imply any human effect, and the material is supplied for laboratory research use only, not for use in or by people.
No third-party batch reports have been uploaded for this product yet. Reports are issued by independent labs after each manufacturing batch.
Calculator
Research planning only
Concentration2.50 mg/ml
Volume to draw0.100 ml
Insulin syringe (100 IU/ml)
10.0units
For research planning only. Not medical, dosing, or therapeutic advice. All Kovalabs products are research-use-only.
Store unreconstituted vials at −20°C for long-term, or refrigerated at 2-8°C for short-term use. Avoid repeated freeze-thaw cycles.
Reconstitute with bacteriostatic water down the inside wall of the vial; gently swirl to dissolve. Do not shake.
Once reconstituted, refrigerate at 2-8°C and use within 2-4 weeks. Discard if cloudy, discoloured, or particulate.